1,313
Views
18
CrossRef citations to date
0
Altmetric
Original Article

In vitro susceptibility of the Gram-negative bacterium Helicobacter pylori to extracts of Iranian medicinal plants

, , , , , , & show all
Pages 77-80 | Received 05 Dec 2007, Accepted 23 Jun 2008, Published online: 01 Jan 2009

Abstract

The susceptibility of Helicobacter pylori to methanol extracts of 12 Iranian medicinal plants used in folk medicine for the treatment of gastric ailments including peptic ulcers disease was screened against one metronidazole-sensitive and one-metronidazole resistant strain of H. pylori using the disk diffusion method. Active extracts (zone of inhibition ≥15 mm) were then re-assayed to obtain the minimum inhibitory concentration (MIC) against 12 clinical isolates of H. pylori by using the agar dilution method. Extracts of the aerial part of Artemisia dracunculus L. (Compositae) and Teucrium polium L. (Lamiaceae), leaves of Salvia mirzayanii Rech. & Esfand. (Lamiaceae) and Salvia officinalis L. (Lamiaceae), flowers of Zataria multiflora Boiss. (Lamiaceae), fruits of Bunium persicum (Boiss.) B. Fedtsch. (Apiaceae), Carum carvi L. (Apiaceae), Heracleum persicum Desf. ex Fischer (Apiaceae), Pimpinella anisum L. (Apiaceae), Trachyspermum copticum (L.) Link (Apiaceae) and Myrtus communis L. (Myrtaceae), and seeds of Nigella sativa L. (Ranunculaceae) were evaluated in the study. Among them, S. mirzayanii had the strongest activity against H. pylori, with a MIC of 32 μg/mL.

Introduction

Helicobacter pylori is a human pathogen, infection with which is directly associated with many diseases of the upper gastrointestinal tract, including acute and chronic gastritis, non-ulcer dyspepsia, peptic ulcer disease, and gastric cancers (CitationWilliamson, 2001). Treatment of H. pylori infection is relatively successful, with usually >80% of patients exhibiting eradication of the organism when combination antibiotic therapies are used (CitationBytzer & O’Morain, 2005). However, bacterial resistance of H. pylori to antibiotics such as clarithromycin and metronidazole has been observed in different parts of the world and continues to increase (CitationGraham & Qureshi, 2000). As a result, there is a need to seek new, safe, and effective anti-H. pylori drugs with highly selective antibacterial activity against the pathogen, but without the risk of resistance and untoward effects.

For thousands of years, plant-based medicines have been used to treat gastrointestinal ailments and, thus, plants would seem to be a logical source of new anti-H. pylori compounds. In fact, strong in vitro evidence suggests that medicinal plants can act as antimicrobial agents against a wide range of bacteria (CitationMansouri et al., 2001; CitationHoffman et al., 2004).

In Iran and the Mediterranean area, herbal extracts have been used as traditional medicines and some medicinal plants are used to treat diseases of the upper gastrointestinal tract (CitationForoumadi et al., 2002). The in vitro anti-H. pylori activities of some Iranian medicinal plants have been previously reported (CitationMalekzadeh et al., 2001; CitationNariman et al., 2004). Furthermore, the anti-H. pylori activities of Greek (CitationStamatis et al., 2003) and Chinese herbal medicines (CitationLi et al., 2005) have also been reported, as well as that of extracts from Taiwanese folk medicinal plants (CitationWang & Huang, 2005).

Accordingly, as a part of a screening program for a number of medicinal plants, we have evaluated a series of native Iranian plants, used traditionally for the treatment of peptic ulcer, on clinical isolates of H. pylori from adult patients.

Materials and methods

Plant material and extraction procedure

Aerial parts of Teucrium polium L. (Lamiaceae) and Artemisia dracunculus L. (Compositae), leaves of Salvia mirzayanii Rech. & Esfand. (Lamiaceae) and Salvia officinalis L. (Lamiaceae), seeds of Nigella sativa L. (Ranunculaceae), and flowering tops of Zataria multiflora Boiss. (Lamiaceae) were collected from Khabr (Kerman Province, Iran) in June 2002; fruits of Bunium persicum (Boiss.) B. Fetsch. (Apiaceae) were collected from the Hezar Mountains (Kerman Province, Iran) in July 2002; and fruits of Carum carvi L. (Apiaceae), Heracleum persicum Desf. ex Fischer (Apiaceae), Myrtus communis L. (Myrtaceae), Pimpinella anisum L. (Apiaceae) and Trachyspermum copticum (L.) Link (Apiaceae) were collected from a farm in Kerman (Kerman Province, Iran) August 2002. The voucher specimens were identified by M. Mehrabani and deposited at the herbarium of the Kerman Faculty of Pharmacy, Kerman, Iran.

The plants were shade-dried and coarsely ground (mesh size: 20) before extraction. Plant material (50 g) was sequentially extracted by exhaustive maceration at room temperature with 1000 mL of methanol. The supernatants were strained through filter paper and evaporated to dryness under vacuum to obtain the methanol extract. A stock solution of the residues was made in methanol at a concentration of 10.24 mg/mL. The final amount of the crude plant extract was 4 mg/disk.

Disk diffusion method

The disk diffusion test was used for primary screening of the plant extracts against two clinical strains of H. pylori, a metronidazole-sensitive and a metronidazole-resistant strain from adult patients. Bacterial suspension, adjusted to yield approximately 1×109 cfu/mL, was streaked with a calibrated loop on plates of Muller–Hinton agar containing 7% defibrinated horse blood. Filter paper disks (6 mm diameter) were placed on the inoculated agar surfaces and impregnated with 40 μL of stock solutions. Pure methanol (40 μL) was used as a negative control. The plates were incubated for 5–7 days at 37°C under microaerophilic conditions.

All tests were performed in triplicate and the antibacterial activity was expressed as the mean of inhibition diameters (mm) produced by the plant extracts. Amoxicillin and metronidazole were used as positive control drugs.

Determination of minimum inhibitory concentration

The active extracts giving an inhibition zone ≥15 mm in diameter were chosen for further determination of the minimum inhibitory concentration (MIC) using the agar dilution method with Muller–Hinton agar containing 7% defibrinated horse blood according to the CitationNCCLS (1998) guidelines (document M7-A4). Pure methanol was used in the assay as a negative control. A stock solution of each extract was serially diluted two-fold in methanol and 1 mL of each dilution was incorporated in 19 mL of melted agar medium and poured into a Petri dish. The final concentrations of the extracts in the medium ranged from 0.1024 to 0.032 mg/mL.

The agar plates were inoculated and then incubated for 5–7 days at 37°C under microaerophilic conditions. The MIC was defined as the lowest concentration of plant extract where there was no visible growth. All determinations were performed in triplicate and a growth control consisting of medium with methanol was included to ensure that the viability of the organisms was not affected by the solvent used to dissolve the plant extracts. For quality control and comparative analysis, the β-lactam antibiotic amoxicillin and metronidazole were also tested with each batch of plant extracts.

Results and discussion

The antimicrobial effects of many herbs have been well known for centuries. Many anti-H. pylori agents exhibiting a significant inhibitory effect have been identified from plant materials. The present study tested the anti-H. pylori activity of several plants from Iranian traditional medicine, which could be used as a useful source of novel drugs, thus supporting traditional regimens.

In the present work, extracts of 12 medical plants from Iran were assessed for their anti-H. pylori properties by using two different methods: the disk inhibition assay, based on diffusion of the plant extract in agar that measured growth inhibition, and an agar dilution assay that measured the MIC of the extracts. The results are presented in and . Eight medicinal plant extracts exhibited an inhibition zone of ≥15 mm, and were further evaluated for their effects on clinical isolates of H. pylori from adult patients.

Table 1. In vitro antibacterial activity of plant extracts against Helicobacter pylori using the disk diffusion method (final amount of crude plant extract=4 mg/disk).

Table 2. In vitro anti-Helicobacter pylori activity of plant extracts against 12 clinical isolates, expressed as minimum inhibitory concentration (μg/mL).

Compared with amoxicillin and metronidazole, the extracts showed inhibitory effects on the growth of H. pylori at higher concentrations; however, the results suggest that the extracts have a considerable antibacterial activity against H. pylori. Among the plants tested, S. mirzayanii, H. persicum, Z. multiflora, and T. polium exhibited the strongest anti-H. pylori activities in the disk diffusion assay (zone of inhibition=20–30 mm).

Among the plant extracts evaluated for MIC, S. mirzayanii was the most active plant, with strong antibacterial activity against clinical isolates of H. pylori (MIC=32–64 μg/mL). S. mirzayanii is widely used in Iranian folk medicine. Decoctions of this plant have many purported medicinal properties and are used in folk medicine for the treatment of digestive disorders. A striking feature of the plant is the pleasant smell of the essential oil, present in numerous glands especially in the leaves.

Recently, it has been reported that the essential oil of C. carvi is weakly active against H. pylori (CitationBergonzelli et al., 2003), which corroborates our results. Another previous investigation of a methanol extract of the seeds of this plant reported the MIC value as 100 μg/mL, also indicating weak activity (CitationMahady et al., 2005).

Previous investigators have reported that an extract obtained from the aerial parts of T. copticum inhibited the growth of H. pylori in vitro (CitationNariman et al., 2004). However, our results showed that the extract of the fruits of this plant had only very weak anti-H. pylori activity.

While some investigators have reported the susceptibility of H. pylori to extracts from the leaves of S. officinalis (CitationMahady et al., 2005; CitationNostro et al., 2005), there was almost no anti-H. pylori activity in the plant extracts of the present study. These data may differ owing to the region where the leaves were collected, the extracts themselves, and the potential difference in plant chemistry of different samples.

In conclusion, the present results showed a significant in vitro susceptibility of clinical strains of H. pylori to extracts of medicine plants used in Iranian traditional medicine. Thus, these plants may be considered a potential new source of agents for the treatment of H. pylori infections, and may be further developed for new and safe agents for inclusion in anti-H. pylori regimens. Further studies are needed to investigate the effects of these active plant extracts and determine the chemical constituents in the extracts responsible to allow for in vivo studies.

Acknowledgment

Declaration of interest: The authors report no conflicts of interest.

References

  • Bergonzelli GE, Donnicola D, Porta N, Corthesy-Theulaz IE (2003), Essential oils as components of a diet-based approach to management of Helicobacter infection. Antimicrob Agents Chemother 47, 3240–3246.
  • Bytzer P, O’Morain C (2005), Treatment of Helicobacter pylori. Helicobacter 10 (Suppl. 1), 40–46.
  • Foroumadi A, Asadipour A, Arabpour F, Amanzadeh Y (2002), Composition of the essential oil of Bunium persicum (Bioss.) B. Fedtsch. from Iran. J Essent Oil Res 14, 161–162.
  • Graham DY, Qureshi WA (2000), Antibiotic resistant H. pylori infection and its treatment. Curr Pharmacol Des 6, 1537–1544.
  • Hoffman BR, DelasAlas H, Blanco K, Wiederhold N, Lewis RE, Williams L (2004), Screening of antibacterial and antifungal activities of ten medicinal plants from Ghana. Pharm Biol 42, 13–17.
  • Li Y, Xu C, Zhang Q, Liu JY, Tan RX (2005), In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicine used to treat ulcer diseases. J Ethnopharmacol 98, 329–333.
  • Mahady GB, Pendland SL, Stoia A, Hamill F, Fabricant D, Dietz BM, Chadwick LR (2005), In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res 19, 988–991.
  • Malekzadeh F, Ehsanifar H, Shahamat M, Levin M, Colwell RR (2001), Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori. Int J Antimirob Agents 18, 85–88.
  • Mansouri S, Foroumadi A, Ghaneie T, Gholamhosseinian NajarA (2001), Antibacterial activity of the crude extracts and fractionated constituents of Myrtus communis. Pharm Biol 39, 399–401.
  • Nariman F, Eftekhar F, Habibi Z, Falsafi T (2004), Anti-Helicobacter pylori activities of six Iranian plants. Helicobacter 9, 146–151.
  • NCCLS (1998), Methods for Antimicrobial Susceptibility Testing for Bacteria that Grow Aerobically; Approved Standard, 4th ed. NCCLS document M7-A4. Wayne, PA, National Committee for Clinical Laboratory Standards.
  • Nostro A, Cellini L, Di Bartolomeo S, Di Campli E, Grande R, Cannatelli MA, Marziol L, Alonzo V (2005), Antibacterial effect of plant extracts against Helicobacter pylori. Phytother Res 19, 198–202.
  • Stamatis G, Kyriazopoulos P, Golegou S, Basayiannis A, Skaltsas S, Skaltsa XH (2003), In vitro anti-Helicobacter pylori activity of Greek herbal medicines. J Ethnopharmacol 88, 175–179.
  • Wang YC, Huang TL (2005), Screening of anti-Helicobacter pylori herbs deriving from Taiwanese folk medicinal plants. FEMS Immunol Med Microbiol 43, 295–300.
  • Williamson JS (2001), Helicobacter pylori: Current chemotherapy and new targets for drug design. Curr Pharm Des 7, 355–392.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.